Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,301 public trials 1,292 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Completed

Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD).

NCT01682083

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site San Francisco, California, United States
  • Novartis Investigative Site San Francisco, California, United States
View all 168 locations
View Trial Details
Completed

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

NCT03881488

Conditions
Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +32 more
Locations
  • Ocala Oncology Center Ocala, Florida, United States
  • Hematology Oncology Associates Of The Treasure Coast Port Saint Lucie, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment

NCT01298323

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +15 more
Locations
  • Investigational Site Number : 301 St Leonards, New South Wales, Australia
  • Investigational Site Number 301 St Leonards, Australia
  • Investigational Site Number 401 Vienna, Austria
  • Investigational Site Number : 401 Vienna, Austria
View all 66 locations
View Trial Details
Completed

HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers

NCT04670016

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +27 more
Locations
  • Alberta Children's Hospital Calgary, Alberta, Canada
  • Stollery Children's Hospital Edmonton, Alberta, Canada
  • British Columbia Children's Hospital Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View all 13 locations
View Trial Details

Related conditions